These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 20372798)

  • 21. Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer.
    Dong T; Zhang M; Dong Y; Herman JG; van Engeland M; Zhong G; Guo M
    Discov Med; 2015 Nov; 20(111):261-71. PubMed ID: 26645898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
    Phuong NT; Kim SK; Lim SC; Kim HS; Kim TH; Lee KY; Ahn SG; Yoon JH; Kang KW
    Breast Cancer Res Treat; 2011 Nov; 130(1):73-83. PubMed ID: 21170675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.
    Yu J; Qin B; Moyer AM; Nowsheen S; Liu T; Qin S; Zhuang Y; Liu D; Lu SW; Kalari KR; Visscher DW; Copland JA; McLaughlin SA; Moreno-Aspitia A; Northfelt DW; Gray RJ; Lou Z; Suman VJ; Weinshilboum R; Boughey JC; Goetz MP; Wang L
    J Clin Invest; 2018 Jun; 128(6):2376-2388. PubMed ID: 29708513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells.
    Worm J; Kirkin AF; Dzhandzhugazyan KN; Guldberg P
    J Biol Chem; 2001 Oct; 276(43):39990-40000. PubMed ID: 11509559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.
    Ehrlichova M; Vaclavikova R; Ojima I; Pepe A; Kuznetsova LV; Chen J; Truksa J; Kovar J; Gut I
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):95-105. PubMed ID: 16059735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, induces cytotoxicity, cell cycle dynamics and alters expression of DNA methyltransferase 1 and 3A in mouse hippocampus-derived neuronal HT22 cells.
    Yang J; Tian X; Yang J; Cui J; Jiang S; Shi R; Liu Y; Liu X; Xu W; Xie W; Jia X; Bade R; Zhang T; Zhang M; Gong K; Yan S; Yang Z; Shao G
    J Toxicol Environ Health A; 2017; 80(22):1222-1229. PubMed ID: 28880816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents.
    Mirza S; Sharma G; Pandya P; Ralhan R
    Mol Cell Biochem; 2010 Sep; 342(1-2):101-9. PubMed ID: 20455010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNMT3B gene amplification predicts resistance to DNA demethylating drugs.
    Simó-Riudalbas L; Melo SA; Esteller M
    Genes Chromosomes Cancer; 2011 Jul; 50(7):527-34. PubMed ID: 21484930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.
    Nandakumar V; Vaid M; Katiyar SK
    Carcinogenesis; 2011 Apr; 32(4):537-44. PubMed ID: 21209038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells.
    Xie Q; Bai Q; Zou LY; Zhang QY; Zhou Y; Chang H; Yi L; Zhu JD; Mi MT
    Genes Chromosomes Cancer; 2014 May; 53(5):422-31. PubMed ID: 24532317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a.
    Liu WB; Cui ZH; Ao L; Zhou ZY; Zhou YH; Yuan XY; Xiang YL; Liu JY; Cao J
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):70-8. PubMed ID: 21163286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.
    Katz TA; Vasilatos SN; Harrington E; Oesterreich S; Davidson NE; Huang Y
    Breast Cancer Res Treat; 2014 Jul; 146(1):99-108. PubMed ID: 24924415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
    Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L
    Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.
    El-Awady RA; Hersi F; Al-Tunaiji H; Saleh EM; Abdel-Wahab AH; Al Homssi A; Suhail M; El-Serafi A; Al-Tel T
    Cancer Biol Ther; 2015; 16(7):1056-70. PubMed ID: 25962089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the combination of RAD001 and docetaxel on breast cancer stem cells.
    Zhang X; Zhang S; Liu Y; Liu J; Ma Y; Zhu Y; Zhang J
    Eur J Cancer; 2012 Jul; 48(10):1581-92. PubMed ID: 22420943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
    J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
    Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
    Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA Methylation Modulates Nociceptive Sensitization after Incision.
    Sun Y; Sahbaie P; Liang D; Li W; Shi X; Kingery P; Clark JD
    PLoS One; 2015; 10(11):e0142046. PubMed ID: 26535894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-141 confers docetaxel chemoresistance of breast cancer cells via regulation of EIF4E expression.
    Yao YS; Qiu WS; Yao RY; Zhang Q; Zhuang LK; Zhou F; Sun LB; Yue L
    Oncol Rep; 2015 May; 33(5):2504-12. PubMed ID: 25813250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells.
    Brown I; Shalli K; McDonald SL; Moir SE; Hutcheon AW; Heys SD; Schofield AC
    Breast Cancer Res; 2004; 6(5):R601-7. PubMed ID: 15318941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.